Omalizumab 150mg/1ml solution for injection pre-filled syringes
NHS hospitals in England used £44,356,215 of indicative cost of Omalizumab 150mg/1ml solution for injection pre-filled syringes in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is down 10.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Omalizumab 150mg/1ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Omalizumab 150mg/1ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £3,629,902 |
| Leeds Teaching Hpls Nhs Trust | £2,753,869 |
| Manchester University Nhs Ft | £2,197,255 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,755,908 |
| Salford Royal Nhs Foundation Trust | £1,525,117 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,395,505 |
| Oxford University Hospitals Nhs Ft | £1,220,555 |
| University Hospitals Plymouth Nhs Trust | £1,197,757 |
| Aintree University Hospital Nhs Ft | £1,061,998 |
| Barts Health Nhs Trust | £1,057,131 |
The primary-care picture
Omalizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Omalizumab medicine page.